Cargando…
Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases
RATIONALE & OBJECTIVE: With a growing number of medications and therapies available to treat chronic kidney disease (CKD), risk-versus-benefit discussions are increasingly critical. Balancing risks and benefits requires assessing patients’ understanding of these, as well as incorporating patient...
Autores principales: | Damron, Kelli Collins, Friedman, Robert, Inker, Lesley A., Thompson, Aliza, Grams, Morgan E., Guðmundsdóttir, Hrefna, Willis, Kerry, Manley, Tom, Heerspink, Hiddo L., Weiner, Daniel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8967726/ https://www.ncbi.nlm.nih.gov/pubmed/35372821 http://dx.doi.org/10.1016/j.xkme.2022.100442 |
Ejemplares similares
-
How to Successfully Develop Treatments for Early-Stage CKD: A Patient Perspective
por: Friedman, Robert
Publicado: (2022) -
Low Turnover Bone Disease in Early CKD Stages
por: Barreto, Fellype Carvalho, et al.
Publicado: (2022) -
Response to “Low Turnover Bone Disease in Early CKD Stages”
por: El-Husseini, Amr, et al.
Publicado: (2022) -
Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study
por: Chase, Herbert S, et al.
Publicado: (2014) -
Qualitative approach to better understand the trajectory of patients with early and moderate stage CKD
por: Engberink, Agnes Oude, et al.
Publicado: (2022)